» Authors » Janneke van de Wijgert

Janneke van de Wijgert

Explore the profile of Janneke van de Wijgert including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 70
Citations 1870
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ebrahimzadeh S, Islam N, Dawit H, Salameh J, Kazi S, Fabiano N, et al.
Cochrane Database Syst Rev . 2022 May; 5:CD013639. PMID: 35575286
Background: Our March 2021 edition of this review showed thoracic imaging computed tomography (CT) to be sensitive and moderately specific in diagnosing COVID-19 pneumonia. This new edition is an update...
2.
Mitratza M, Goodale B, Shagadatova A, Kovacevic V, van de Wijgert J, Brakenhoff T, et al.
Lancet Digit Health . 2022 Apr; 4(5):e370-e383. PMID: 35461692
Containing the COVID-19 pandemic requires rapidly identifying infected individuals. Subtle changes in physiological parameters (such as heart rate, respiratory rate, and skin temperature), discernible by wearable devices, could act as...
3.
Delvaux T, Jespers V, Benova L, van de Wijgert J
Front Glob Womens Health . 2021 Dec; 2:799963. PMID: 34970653
Acceptability of and satisfaction with contraceptive methods are paramount for uptake and continuation. In the current context of multipurpose prevention of pregnancy and sexually transmitted diseases/HIV development, it is critical...
4.
Mirzayi C, Renson A, Zohra F, Elsafoury S, Geistlinger L, Kasselman L, et al.
Nat Med . 2021 Nov; 27(11):1885-1892. PMID: 34789871
The particularly interdisciplinary nature of human microbiome research makes the organization and reporting of results spanning epidemiology, biology, bioinformatics, translational medicine and statistics a challenge. Commonly used reporting guidelines for...
5.
Brakenhoff T, Franks B, Goodale B, van de Wijgert J, Montes S, Veen D, et al.
Trials . 2021 Oct; 22(1):694. PMID: 34635140
Objectives: It is currently thought that most-but not all-individuals infected with SARS-CoV-2 develop symptoms, but the infectious period starts on average 2 days before the first overt symptoms appear. It...
6.
Brakenhoff T, Franks B, Goodale B, van de Wijgert J, Montes S, Veen D, et al.
Trials . 2021 Jun; 22(1):412. PMID: 34158099
Objectives: It is currently thought that most-but not all-individuals infected with SARS-CoV-2 develop symptoms, but that the infectious period starts on average two days before the first overt symptoms appear....
7.
Islam N, Ebrahimzadeh S, Salameh J, Kazi S, Fabiano N, Treanor L, et al.
Cochrane Database Syst Rev . 2021 Mar; 3:CD013639. PMID: 33724443
Background: The respiratory illness caused by SARS-CoV-2 infection continues to present diagnostic challenges. Our 2020 edition of this review showed thoracic (chest) imaging to be sensitive and moderately specific in...
8.
Islam N, Salameh J, Leeflang M, Hooft L, McGrath T, van der Pol C, et al.
Cochrane Database Syst Rev . 2020 Nov; 11:CD013639. PMID: 33242342
Background: The respiratory illness caused by SARS-CoV-2 infection continues to present diagnostic challenges. Early research showed thoracic (chest) imaging to be sensitive but not specific in the diagnosis of coronavirus...
9.
Salameh J, Leeflang M, Hooft L, Islam N, McGrath T, van der Pol C, et al.
Cochrane Database Syst Rev . 2020 Sep; 9:CD013639. PMID: 32997361
Background: The diagnosis of infection by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents major challenges. Reverse transcriptase polymerase chain reaction (RT-PCR) testing is used to diagnose a current...
10.
Ten Doesschate T, Moorlag S, van der Vaart T, Taks E, Debisarun P, Ten Oever J, et al.
Trials . 2020 Jun; 21(1):555. PMID: 32571383
An amendment to this paper has been published and can be accessed via the original article.